Refractory remodelling of the microenvironment by type V collagen and apoptosis in non small cell lung cancer Source: Annual Congress 2009 - Pathogenesis of lung cancer Year: 2009
A low endothelial cell proliferation fraction, a measurement of ongoing angiogenesis, is associated with poor prognosis in non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 763s Year: 2006
Inverse correlation between the expression of vascular endothelial growth factor and infiltration of dendritic cells and their influence on the prognosis of nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 13s Year: 2002
The role of cell lines in modelling the type II pneumocyte in interstitial lung disease Source: Virtual Congress 2020 – Human ex vivo models of interstitial lung disease Year: 2020
Expression of vascular endothelial growth factor (VEGF) and association with lymphangiogenesis in non small cell (NSCLC) and small cell lung carcinomas (SCLC) Source: Eur Respir J 2006; 28: Suppl. 50, 386s Year: 2006
The effect of matrix metalloproteinase-9 and vascular endothelial growth factor expression on survival of non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 324s Year: 2005
Differential effects of collagen I and III and vitronectin on proliferation and apoptosis of human lung fibroblasts Source: Eur Respir J 2004; 24: Suppl. 48, 105s Year: 2004
IRP2 as a potential modulator of cell proliferation, apoptosis and prognosis in nonsmall cell lung cancer Source: Eur Respir J , 49 (4) 1600711; DOI: 10.1183/13993003.00711-2016 Year: 2017
Nasal tolerance promotes increase in tumoral type V collagen protein synthesis and vascular apoptosis in the mouse lung chemical carcinogenesis Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010
RANKL contributes to lung tissue repair via promoting type II epithelial cell proliferation Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro Year: 2020
PP126 – RANKL contributes to lung tissue repair via promoting type II epithelial cell proliferation Source: ERS Lung Science Conference 2021 Year: 2021
The role of serum adhesion molecules and vascular endothelial growth factor in the treatment approach of the lung cancer patients Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009
Decreased VEGF concentration in lung tissue and vascular injury during ARDS Source: Eur Respir J 2005; 25: 139-146 Year: 2005
Overexpression of inhibitor of DNA-binding proteins and angiogenic markers have higher impact on survival of non small cell lung cancer patients Source: Annual Congress 2012 - New insights in the pathology of lung cancer Year: 2012
The effect of siRNA on invasion capability of small cell lung cancer Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012
CHD4 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor cell proliferation Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016
Expression of vascular endothelial growth factor (VEGF) and its receptors (VEFG-R1-Flt1, VEGF-R2-Flk1) in non small cell lung carcinomas (NSCLC): correlation with lymphangiogenesis and clinical outcome Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007
MiR-34a favours macrophage polarization switch from M2 to M1 phenotype in non small cell lung cancer (NSCLC) Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020
NEUROD1 is highly expressed in extensive disease small cell lung cancer by promoting migration. Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020
Down regulation of type V collagen triggers angiogenesis and immune response disfunction in lung cancer microenvironment Source: Annual Congress 2010 - New insights in the pathology of lung cancer Year: 2010